Singapore markets closed
Straits Times Index
3,303.66 +12.96 (+0.39%) S&P 500
5,226.31 +3.63 (+0.07%) Dow
39,577.74 +64.90 (+0.16%) Nasdaq
16,373.24 +32.38 (+0.20%) Bitcoin USD
62,914.04 +1,702.11 (+2.78%) CMC Crypto 200
1,296.77 +36.57 (+2.90%)
GSK Aug 2024 32.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:33AM EDT. Market open.
| Previous close | 7.90 |
| Open | N/A |
| Bid | 12.80 |
| Ask | 13.90 |
| Strike | 32.00 |
| Expiry date | 2024-08-16 |
| Day's range | 7.90 - 7.90 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
Simply Wall St.GSK plc (LON:GSK) Stock Goes Ex-Dividend In Just Four Days
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see GSK plc...
- Simply Wall St.
GSK (LON:GSK) Is Paying Out A Dividend Of £0.15
GSK plc's ( LON:GSK ) investors are due to receive a payment of £0.15 per share on 11th of July. The dividend yield...
GlobeNewswireBioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 Million
Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of tuberculosisGSK to participate in Series C Extension with equity investmentSeries C financing round extended overall by CHF 12.3 million to CHF 44.9 million BASEL, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- BioVersys AG, a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections
© 2024 Yahoo. All rights reserved.